LeMaitre Vascular Inc (LMAT)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $1.76B
Last updated: Nov 17, 2026 at 4:15 PM ET
LeMaitre Vascular Inc (LMAT) Stock Chart
LeMaitre Vascular (LMAT) has a latest price of $76.10 on Nov 17, 2026. Its price fell 13.3% over the past 12 months. The month-end price rose 286.5% over the 10 years through Oct 2026, a compound annual rate of 14.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $109.75 in Apr 2026 and its lowest $20.94 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart LMAT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LMAT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 9.0%, and over 6 months it fell 24.5%. The month-end price rose 66.6% over the 3 years through Oct 2026, a compound annual rate of 18.6%.
| Period | Change |
|---|---|
| 1 month | -7.5% |
| 3 months | -9.0% |
| 6 months | -24.5% |
| 12 months | -13.3% |
| 12 months, with dividends | -12.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +66.6% | +18.6% |
| 5 years | +55.6% | +9.2% |
| 10 years | +286.5% | +14.5% |
Price by Year
Its best calendar year was 2024, when the price rose 62.3%, and its weakest was 2018, when it fell 25.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $80.94 | -0.2% |
| 2025 | $81.10 | -12.0% |
| 2024 | $92.14 | +62.3% |
| 2023 | $56.76 | +23.3% |
| 2022 | $46.02 | -8.4% |
| 2021 | $50.23 | +24.0% |
| 2020 | $40.50 | +12.7% |
| 2019 | $35.95 | +52.1% |
| 2018 | $23.64 | -25.8% |
| 2017 | $31.84 | +25.7% |
Trading Range
The price is 6.2% below its 50-day average of $81.17 and 18.9% below its 200-day average of $93.86.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $76.10 | |
| 50-day average | $81.17 | -6.2% |
| 200-day average | $93.86 | -18.9% |
Price Risk
Over 3 years, its largest fall from a peak was 34.8%.
| Measure | Value |
|---|---|
| 1-year beta | 0.60 |
| Largest fall, 1 year | -34.8% |
| Largest fall, 3 years | -34.8% |
Valuation
LeMaitre Vascular traded at 32.3x earnings at the end of 2025, against a 5-year median of 43.0x and a 10-year median of 41.2x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About LMAT
What is LMAT's 1-year price change?
LeMaitre Vascular's price fell 13.3% over the past 12 months. With dividends included, the 12-month total return was -12.2%.
What is LMAT's 5-year price change?
LeMaitre Vascular's month-end price rose 55.6% over the 5 years through Oct 2026, a compound annual rate of 9.2%. These figures leave out dividends.
What is LMAT's beta?
LeMaitre Vascular's 1-year beta against the S&P 500 is 0.60, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 34.8%.
Is the LMAT chart free?
Yes. Advanced Charting for LMAT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
LMAT pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts